Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

Brains Need Open Minds campaign, the largest in The Neuro’s history, has fueled innovative brain research

An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.

96 Global Health NOW: Big Tobacco’s Legislative Coups; and Senegal’s Disease Sentinel View this email in your browser November 11, 2025 Forward Share Post TOP STORIES Canada—and, by extension, the entire Americas region—has officially lost its measles elimination status; the designation is reversible, however, if the current outbreak ends and no new cases are reported for a year. STAT     Millions of young children with neglected tropical diseases currently excluded from ivermectin treatment could be safely included, per a double-blinded trial testing the drug’s safety and efficacy on small children with scabies in The Gambia, Kenya, and Brazil. CIDRAP 
  Ukrainian medics are reporting cases of gas gangrene, a bacterial infection not seen in Europe for generations; they blame dramatically slowed evacuations of wounded soldiers caused by drone warfare. The Telegraph
  The FDA lifted a black box warning about stroke, heart attack, dementia, and other risks from hormone-based menopause drugs yesterday; some physicians hailed the move, but others questioned the lack of transparency in the process. AP  IN FOCUS Customs officers burn cigarettes seized from illegal trade during a press conference in Banda Aceh, Indonesia, on July 22. Chaideer Mahyuddin/AFP via Getty Big Tobacco’s Legislative Coups    Aggressive tobacco industry tactics have beat back legislation against its products and garnered support from multiple countries in the past two years, according to a report released this morning that tracks industry interference.  
  Tactics: Industry has won favor by paying for junkets (such as visiting Philip Morris International’s facility in Switzerland), promising investment and jobs, and showcasing corporate social responsibility projects that draw attention from its negative impacts.  
Big Tobacco wins:  

• Legislative leaders in 14 countries have filed pro-industry bills or delayed passage of new anti-tobacco laws, per the report by the Global Center for Good Governance in Tobacco Control and STOP, an industry watchdog. 

• 20 countries have signed memorandums of understanding with tobacco companies to tackle tobacco smuggling. 

• 10 countries have delayed or rejected tax increases. 

Better news:  

• 18 countries have adopted new anti-tobacco measures. 

• 20+ countries have banned donations from the tobacco industry. 

• 46 have banned e-cigarettes. 

High costs: Tobacco killed 7 million people in 2023, and caused $1.7 trillion in health care expenses and losses in productivity. 
The Quote: “Tobacco taxes should go up more so people will smoke less and governments can fund other health priorities,” says report lead author Mary Assunta, in a Guardian commentary. 
Related: Smoked out: How Europe’s illegal tobacco market drains public coffers – Euractiv  GLOBAL HEALTH VOICES HEALTH SURVEILLANCE Senegal’s Disease Sentinel 
  When patients at clinics throughout Senegal test positive for diseases like malaria, their cases are linked to a digital “web of surveillance” maintained by hospitals and clinics throughout the country.  

• The system, Senegal’s Syndromic Sentinel Surveillance System (“4S”), is run by the Institut Pasteur de Dakar, and allows health officials to quickly trace disease patterns in real time.  

• So far, the system has flagged malaria mutations, dengue outbreaks, and the spread of West Nile virus.  

Regional expansion: The 4S model now spans 10 West African countries, creating a “regional tripwire” that detects outbreaks.  
  Funding threats: U.S. aid cuts this year threaten the network’s growth, even as scientists call it essential to Africa’s epidemic preparedness.    The Telegraph OPPORTUNITY QUICK HITS An emerging shutdown deal doesn’t extend expiring health subsidies. Here’s what could happen to them – AP

Vaccine advice: how a US centre is filling growing gaps in public-health information – Nature

The anti-vaccine movement isn’t satisfied with winning over the GOP – Politico

‘Why I flew to Cambodia to vaccinate dogs after watching my mum die of rabies’ – The Telegraph

A Grave Condition Caused by C-Sections Is on the Rise – The New York Times (gift link)

How a childhood virus can contribute to dementia later and what you can do – The Washington Post (gift link)

In Defence of E-Bikes – Macleans Issue No. 2820
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.

Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.

Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe

Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
  Copyright 2025 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

96 Global Health NOW: A Sharp Climb in Kidney Disease; and The Possibilities and Predicaments of Artificial Wombs View this email in your browser November 10, 2025 Forward Share Post TOP STORIES One-Liners   Seven Democratic senators agreed to advance an agreement to end the U.S. government shutdown, accepting a Republican promise to vote on “extending Affordable Care Act subsidies set to expire at the end of the year.” The Washington Post (gift link)  
Nigeria’s Lassa fever death toll has reached 176 so far this year, with 955 confirmed cases, CIDRAP reports; meanwhile, a candidate Lassa fever vaccine has been found safe and created a strong immune response in adults, per CIDRAP.      Indonesian mothers are leading mass protests after thousands of students suffered food poisoning from the country’s new free meals program meant to stem malnutrition and stunted growth. The Guardian    The U.S. is demanding that countries agree to share information on “pathogens with epidemic potential” in exchange for restoring some health aid—without assurances of fair access to vaccines, treatments, and diagnostics developed from shared information; the bilateral deals could “potentially torpedo” a WHO-led system under negotiation. Health Policy Watch  IN FOCUS A nurse cares for a hemodialysis patient at the Yuping Dong Autonomous County People's Hospital, in Tongren, Guizhou province, China, on February 26. Costfoto/NurPhoto via Getty A Sharp Climb in Kidney Disease    Chronic kidney disease (CKD) is now the ninth leading cause of death globally, up from the 27th in 1990, finds a landmark study published last week in The Lancet.     By the numbers: In 2023, CKD affected ~788 million people ages 20+ worldwide, or ~14% of the global population—up from ~12% in 1990.  

• The disease also claimed 1.48 million lives.  

Driving factors: Researchers say the increase is tied to the global rise in diabetes, high blood pressure, and obesity, all of which damage blood vessels and strain the kidneys, reports The New York Times (gift link). It is also reflective of an aging population.      Global overview: China has the largest population living with CKD at 152 million, followed by India at 138 million, reports PTI.  

• Prevalence is highest in North Africa and the Middle East.  

The need for screening: The condition remains underdiagnosed, say nephrologists, who stressed the need for a wider adoption of blood and urine tests for at-risk individuals, reports MedPage Today.  

• A range of recently developed drugs and interventions can slow kidney damage—but early diagnosis is critical. 

DATA POINT


250 million
———————
People forced to flee their homes by weather-related disasters over the past decade, per a UNHCR report coinciding with today’s launch of the 30th annual UN Climate Change conference (COP) in Belém, Brazil. —Al Jazeera
  INFANT MORTALITY The Possibilities and Predicaments of Artificial Wombs      Scientists have made significant strides in efforts to develop an “artificial womb” that can help extremely premature babies survive outside of the human body.    A delicate process: One prototype created by Dutch startup AquaWomb is a fluid-filled, temperature-controlled vessel where a baby’s umbilical cord connects to a mechanical placenta that delivers oxygen and nutrients until the infant’s lungs mature.    And an ethical debate: Bioethicists warn that artificial wombs could raise new moral and legal questions around viability, and reframe reproductive policy.     Where development stands: The technology has already been used with fetal lambs. 

• In 2023, the U.S. FDA convened experts to consider allowing the first human trials; however, the agency has not signaled if or when such trials could be greenlighted.  

The Guardian  GLOBAL HEALTH VOICES QUICK HITS Waiting for the all-clear: how medics and villagers rallied when Ebola returned to DRC  – The Guardian    Disinvesting in the future leadership of global health has already begun: What can we do about it? – PLOS Global Public Health (commentary)     The fight over SNAP benefits continues — and so does the mom guilt – The 19th 
Doctor in Sudan wins $1 million prize for his extraordinary courage: 'It is my duty' – NPR Goats and Soda 
Pressure to publish is rising as research time shrinks, finds survey of scientists – Nature  
Disease of 1,000 faces shows how science is tackling immunity’s dark side – AP 
Hospital CEO Pay Is Too Damn High – MedPage Today (commentary) Thanks for the tip, Chiara Jaffe!   Issue No. 2819
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.

Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.

Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe

Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
  Copyright 2025 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

As health emergencies multiply linked to the climate crisis, governments are joining forces with the UN to protect access to clean water, while data indicates that 118 million people in Europe alone live near healthcare facilities lacking basic sanitation.  

Comme projet de société, notre système de santé public ne doit laisser personne pour compte.

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you

No appointment needed.

First come, first serve.

 

Thank you